annual EBITDA:
-$492.89M-$312.91M(-173.87%)Summary
- As of today (June 17, 2025), DNLI annual EBITDA is -$492.89 million, with the most recent change of -$312.91 million (-173.87%) on December 31, 2024.
- During the last 3 years, DNLI annual EBITDA has fallen by -$205.73 million (-71.64%).
- DNLI annual EBITDA is now -791.78% below its all-time high of $71.25 million, reached on December 31, 2020.
Performance
DNLI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$142.37M-$15.14M(-11.90%)Summary
- As of today (June 17, 2025), DNLI quarterly EBITDA is -$142.37 million, with the most recent change of -$15.14 million (-11.90%) on March 31, 2025.
- Over the past year, DNLI quarterly EBITDA has dropped by -$12.28 million (-9.44%).
- DNLI quarterly EBITDA is now -157.83% below its all-time high of $246.20 million, reached on December 31, 2020.
Performance
DNLI quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$505.16M-$12.28M(-2.49%)Summary
- As of today (June 17, 2025), DNLI TTM EBITDA is -$505.16 million, with the most recent change of -$12.28 million (-2.49%) on March 31, 2025.
- Over the past year, DNLI TTM EBITDA has dropped by -$305.87 million (-153.48%).
- DNLI TTM EBITDA is now -809.01% below its all-time high of $71.25 million, reached on December 31, 2020.
Performance
DNLI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DNLI EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -173.9% | -9.4% | -153.5% |
| 3 y3 years | -71.6% | -121.0% | -78.8% |
| 5 y5 years | -140.2% | -146.1% | -126.6% |
DNLI EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -173.9% | at low | -182.4% | at low | -249.4% | at low |
| 5 y | 5-year | -791.8% | at low | -157.8% | at low | -809.0% | at low |
| alltime | all time | -791.8% | at low | -157.8% | at low | -809.0% | at low |
DNLI EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$142.37M(+11.9%) | -$505.16M(+2.5%) |
| Dec 2024 | -$492.89M(+173.9%) | -$127.23M(+5.2%) | -$492.89M(-0.6%) |
| Sep 2024 | - | -$120.92M(+5.5%) | -$496.05M(+1.9%) |
| Jun 2024 | - | -$114.65M(-11.9%) | -$486.71M(+144.2%) |
| Mar 2024 | - | -$130.09M(-0.2%) | -$199.29M(+10.7%) |
| Dec 2023 | -$179.97M(-45.5%) | -$130.40M(+16.9%) | -$179.97M(+19.3%) |
| Sep 2023 | - | -$111.58M(-164.6%) | -$150.83M(+4.3%) |
| Jun 2023 | - | $172.77M(-256.0%) | -$144.60M(-61.6%) |
| Mar 2023 | - | -$110.77M(+9.4%) | -$376.71M(+14.0%) |
| Dec 2022 | -$330.36M(+15.0%) | -$101.25M(-3.9%) | -$330.36M(+8.6%) |
| Sep 2022 | - | -$105.34M(+77.5%) | -$304.13M(+7.8%) |
| Jun 2022 | - | -$59.34M(-7.9%) | -$282.20M(-0.1%) |
| Mar 2022 | - | -$64.42M(-14.1%) | -$282.46M(-1.6%) |
| Dec 2021 | -$287.16M(-503.0%) | -$75.03M(-10.0%) | -$287.16M(-942.9%) |
| Sep 2021 | - | -$83.41M(+39.9%) | $34.07M(-42.8%) |
| Jun 2021 | - | -$59.61M(-13.7%) | $59.51M(-0.8%) |
| Mar 2021 | - | -$69.11M(-128.1%) | $59.99M(-15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $71.25M(-134.7%) | $246.20M(-524.8%) | $71.25M(-130.9%) |
| Sep 2020 | - | -$57.96M(-2.0%) | -$230.65M(+4.4%) |
| Jun 2020 | - | -$59.13M(+2.2%) | -$220.96M(-0.9%) |
| Mar 2020 | - | -$57.86M(+3.9%) | -$222.95M(+8.7%) |
| Dec 2019 | -$205.19M(+426.7%) | -$55.70M(+15.4%) | -$205.19M(+183.5%) |
| Sep 2019 | - | -$48.27M(-21.0%) | -$72.39M(+21.1%) |
| Jun 2019 | - | -$61.12M(+52.4%) | -$59.76M(+10.3%) |
| Mar 2019 | - | -$40.10M(-152.0%) | -$54.17M(+39.0%) |
| Dec 2018 | -$38.96M(-55.3%) | $77.10M(-316.4%) | -$38.96M(-71.9%) |
| Sep 2018 | - | -$35.64M(-35.8%) | -$138.79M(+11.3%) |
| Jun 2018 | - | -$55.53M(+123.1%) | -$124.66M(+37.1%) |
| Mar 2018 | - | -$24.89M(+9.5%) | -$90.94M(+4.5%) |
| Dec 2017 | -$87.06M(+1.3%) | -$22.73M(+5.7%) | -$87.06M(+4.4%) |
| Sep 2017 | - | -$21.51M(-1.3%) | -$83.42M(+34.7%) |
| Jun 2017 | - | -$21.80M(+3.8%) | -$61.91M(+54.4%) |
| Mar 2017 | - | -$21.01M(+10.1%) | -$40.10M(+110.1%) |
| Dec 2016 | -$85.96M(+419.2%) | -$19.09M | -$19.09M |
| Dec 2015 | -$16.56M | - | - |
FAQ
- What is Denali Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Denali Therapeutics?
- What is Denali Therapeutics annual EBITDA year-on-year change?
- What is Denali Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Denali Therapeutics?
- What is Denali Therapeutics quarterly EBITDA year-on-year change?
- What is Denali Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Denali Therapeutics?
- What is Denali Therapeutics TTM EBITDA year-on-year change?
What is Denali Therapeutics annual EBITDA?
The current annual EBITDA of DNLI is -$492.89M
What is the all time high annual EBITDA for Denali Therapeutics?
Denali Therapeutics all-time high annual EBITDA is $71.25M
What is Denali Therapeutics annual EBITDA year-on-year change?
Over the past year, DNLI annual EBITDA has changed by -$312.91M (-173.87%)
What is Denali Therapeutics quarterly EBITDA?
The current quarterly EBITDA of DNLI is -$142.37M
What is the all time high quarterly EBITDA for Denali Therapeutics?
Denali Therapeutics all-time high quarterly EBITDA is $246.20M
What is Denali Therapeutics quarterly EBITDA year-on-year change?
Over the past year, DNLI quarterly EBITDA has changed by -$12.28M (-9.44%)
What is Denali Therapeutics TTM EBITDA?
The current TTM EBITDA of DNLI is -$505.16M
What is the all time high TTM EBITDA for Denali Therapeutics?
Denali Therapeutics all-time high TTM EBITDA is $71.25M
What is Denali Therapeutics TTM EBITDA year-on-year change?
Over the past year, DNLI TTM EBITDA has changed by -$305.87M (-153.48%)